NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) is commencing today, through its wholly owned subsidiary Puma Acquisition Corporation, a cash tender offer to purchase all outstanding shares of common stock of Medarex, Inc. (NASDAQ:MEDX). Bristol-Myers Squibb announced on Wednesday, July 22 its intent to acquire Medarex.
